Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (271-280 of 322) with videos related to

Pageof 33
Sort By:
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Nature Cell Biology|December 30, 2025
T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune responseLaurianne Scourzic, Franco Izzo, Matt Teater, et al.
Cancer Cell|October 1, 2019
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic ColonizationAna P Gomes, Didem Ilter, Vivien Low, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2023
Distinct and opposite effects of leukemogenic <i>Idh</i> and <i>Tet2</i> mutations in hematopoietic stem and progenitor cellsJerome Fortin, Ming-Feng Chiang, Cem Meydan, et al.
Nature Communications|April 25, 2019
Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLLAlessandro Pastore, Federico Gaiti, Sydney X Lu, et al.
Nature Communications|September 27, 2022
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphomaTatiana Erazo, Chiara M Evans, Daniel Zakheim, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Oncogene|April 1, 2014
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphomaP-Y Kuo, V V Leshchenko, M J Fazzari, et al.
Nature Communications|April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironmentJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Blood Cancer Journal|September 23, 2022
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, et al.
Pageof 33

Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Nature Cell Biology|December 30, 2025
T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune responseLaurianne Scourzic, Franco Izzo, Matt Teater, et al.
Cancer Cell|October 1, 2019
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic ColonizationAna P Gomes, Didem Ilter, Vivien Low, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2023
Distinct and opposite effects of leukemogenic <i>Idh</i> and <i>Tet2</i> mutations in hematopoietic stem and progenitor cellsJerome Fortin, Ming-Feng Chiang, Cem Meydan, et al.
Nature Communications|April 25, 2019
Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLLAlessandro Pastore, Federico Gaiti, Sydney X Lu, et al.
Nature Communications|September 27, 2022
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphomaTatiana Erazo, Chiara M Evans, Daniel Zakheim, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Oncogene|April 1, 2014
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphomaP-Y Kuo, V V Leshchenko, M J Fazzari, et al.
Nature Communications|April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironmentJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Blood Cancer Journal|September 23, 2022
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, et al.
Pageof 33